Fact based stock research
St. Jude Medical ()




Research has been discontinued. Contact us if you want research on this stock.



St. Jude Medical stock research in summary

sjm.com


St. Jude Medical shares have a SELL rating. While they show above average growth, they are riskily financed, and are bad value. We recommend selling St. Jude Medical shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Equipment
Index
Size class Large

December 31, 2016. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()







 

Research History: St. Jude Medical

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
65
36
23
23
STOCK GROWTH RANKS
22
33
67
67
STOCK SAFETY RANKS
39
32
39
39
COMBINED STOCK RANKS
57
5
30
30

Last update of Combined Rank: 31-Dec-2016. Stock research history is based on the Obermatt Method. The higher the rank, the better is St. Jude Medical in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2015 2016 2017 2018
PRICE VS. REVENUES (P/S)
33
28
27
27
PRICE VS. PROFITS (P/E)
87
48
57
57
PRICE VS. CAPITAL (Market-to-Book)
25
11
47
47
DIVIDEND YIELD
95
82
1
1
CONSOLIDATED RANK: VALUE
65
36
23
23

Last update of Value Rank: 31-Dec-2016. Stock analysis on value ratios: The higher the rank, the lower the value ratio of St. Jude Medical; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
26
48
52
52
PROFIT GROWTH
1
9
46
46
STOCK RETURNS
12
69
87
87
CONSOLIDATED RANK: GROWTH
22
33
67
67

Financial reporting date of Growth Rank: 31-Dec-2016. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of St. Jude Medical.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
29
11
37
37
REFINANCING
43
43
LIQUIDITY
64
55
46
46
CONSOLIDATED RANK: SAFETY
39
32
39
39

Financial reporting date of Safety Rank: 31-Dec-2016. Stock analysis on safety metrics: The higher the rank, the lower the leverage of St. Jude Medical and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for St. Jude Medical from December 31, 2016.